For solids we use the 3D spatially unsplit Eulerian solid mechanics method of Miller and Colella.
On the basis of the entropy reduction of the crystalline phase near a charged solid surface, we used a modification of the classical heterogeneous nucleation theory to explain the observed freezing temperatures lessening.
For 454, Illumina and SOLiD reads, we used Newbler2.0.01.14, BWA0.5.9-r16 [ 18], and Bioscope1.3 http://www.appliedbiosystems.com.cn/ to perform the alignment with default parameters, respectively.
If the contents were solid inside, we used a small curette carefully without damaging the wall and washed the remnants with 0.9% NaCl solution to ensure that all the contents were removed.
Taking into consideration the limitation of using ALCL as a positive control because of high concentration of ALK protein epitopes as compared with solid tumours, we used a lower dilution of the ALK antibody (1 : 100) to ensure optimal detection of low concentration of the ALK protein in CRC.
To elute protein complexes from solid support we used elution buffer (62.5 mM TrisHCl pH 6.8, 2% SDS, 10% glycerol, 15.5 mg mL 1 DTT, bromophenol blue 0.02 mg mL 1) and boiled the sample at 100 °C for 3 min. Protein lysates were prepared using 20 mM Tris pH 7.4, 25 mM NaCl, 0.1% NP-40 lysis buffer.
To quantify the rate at which solids mix laterally, we used a lateral dispersion coefficient (Dsr).
The second type of porous body was again a deposit, but instead of solid submicrometer particles, we used very large, porous glass spheres.
To evaluate their solid polymer degrading activity, we used PBSA film (Bionolle 3001 G) and PBS film (Bionolle 1001G), both of which have an average molecular weight of 20 to 25 × 104 and a thickness of 20 μm.
To investigate the effect of genistein treatment on signaling pathways operative in different solid human tumors, we used the following human cell lines: HS68 (fibroblasts), NCCIT (embryonal cancer cell line), U373 (glioma cell line), MCF7 (breast cancer cell line), HCC (hepatocellular carcinoma), HCC-M (metastasis of HCC) GBM1207 (primary glioblastoma), and eRMS (embryonic Rhabdomyosarcoma).
